RANI – rani therapeutics holdings, inc. - class a (US:NASDAQ)
Stock Stats
News
Rani Therapeutics Holdings, Inc. (NASDAQ: RANI) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $9.00 price target on the stock.
Rani Therapeutics Announces New Preclinical Pharmacokinetic Data Supporting Transenteric Delivery of GLP-1 Incretin Triagonist
Rani Therapeutics to sell 3M shares at $3.00 in registered direct offering [Seeking Alpha]
Rani Therapeutics Holdings, Inc. Announces Pricing of $10.0 Million Registered Direct Offering and Cancellation of Certain Existing Warrants
Oppenheimer Predicts up to 740% Rally for These 2 ‘Strong Buy' Stocks [Yahoo! Finance]
Form SC 13D/A Rani Therapeutics Holdin Filed by: South Lake One LLC
Form 4 Rani Therapeutics Holdin For: Oct 15 Filed by: South Lake One LLC
Form 8-K Rani Therapeutics Holdin For: Oct 15
Form 424B5 Rani Therapeutics Holdin
Form 8-K Rani Therapeutics Holdin For: Sep 10
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.